Gadicke Ansbert is a director of Tcr2 Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
TCR2 THERAPEUTICS INC.
5 Jun 23
4
TCR2 THERAPEUTICS INC.
24 May 23
5
Cullinan Oncology, Inc.
10 Feb 23
4
Allovir, Inc.
1 Aug 22
4
Cullinan Oncology, Inc.
23 Jun 22
4
Allovir, Inc.
19 May 22
4
Cullinan Oncology, Inc.
25 Mar 22
4
iTeos Therapeutics, Inc.
6 Jan 22
4
iTeos Therapeutics, Inc.
7 Dec 21
4
iTeos Therapeutics, Inc.
2 Dec 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
1 Jun 23 | TCRR Tcr2 Therapeutics | Common Stock | Other | Dispose J | Yes | No | 0 | 3,370,982 | 0.00 | 0 |
1 Jun 23 | TCRR Tcr2 Therapeutics | Common Stock | Other | Dispose J | Yes | No | 0 | 3,854,963 | 0.00 | 0 |
1 Jun 23 | TCRR Tcr2 Therapeutics | Common Stock | Other | Dispose J | Yes | No | 0 | 304,001 | 0.00 | 0 |
22 May 23 | TCRR Tcr2 Therapeutics | Common Stock | Sell | Dispose S | Yes | No | 1.88 | 70,170 | 131.92 k | 304,001 |
22 May 23 | TCRR Tcr2 Therapeutics | Common Stock | Acquire X | Yes | No | 0.74 | 178,269 | 131.92 k | 374,171 | |
22 May 23 | TCRR Tcr2 Therapeutics | Common Stock Warrant Common Stock | Dispose X | Yes | No | 0.74 | 135,508 | 100.28 k | 0 | |
22 May 23 | TCRR Tcr2 Therapeutics | Common Stock Warrant Common Stock | Dispose X | Yes | No | 0.74 | 42,761 | 31.64 k | 0 |